Timely Insights for Healthcare Experts
PEPIDPrimer: 10 Basic Critical Appraisal Questions for Healthcare Professionals and Librarians
Using Critical Appraisal to Find the Best Resources in the Midst of 'Information Overload' The rise of evidence-based practice (EBP) has been transformative in accomplishing value-based provider goals and improving patient outcomes. Over 12,000 new articles are...
read more
An Infographic World Immunization Week
About World Immunization Week World Immunization Week is a global public health campaign to raise awareness and increase rates of immunization against vaccine-preventable diseases around the world. World immunization week takes place each year during the last week of...
read more
DO Your Part, Doc! How Doctors of Osteopathic Medicine Can Save an Aging America
A 2018 report conducted for the Association of American Medical Colleges (AAMC) by IHS Inc paints a grim picture for the increasing healthcare demands of a growing & aging population with a physician supply that is struggling to keep up. The predicted physician...
read more
Starting the Conversations with your Patients to Donate Life
It's Donate Life Month, here's how to inspire your patients to donate! 2017 was the fifth year in a row for record breaking numbers of organ, eye, and tissue transplants in the United States. Time reports that the 34,768 transplants in 2017 constitute “more than a 3%...
read more
Diagnosis or Wake Up Call? How to Educate and Motivate the Prediabetic Patient
1 in 4 Adults are Still Unaware That They are Living with Diabetes. For how seriously debilitating and life-altering diabetes can be for about 30.3 million diagnosed Americans, the American Diabetes Association (ADA) estimates that nearly 1 in 4 adults, or 7.2 million...
read more
PEPID’s Founder and CEO Discusses the Challenges and Merits of PGx
Founder and CEO, Mark Rosenbloom, MD, MBA joins PEPID Pulse’s Implementing Precision Medicine live broadcast series at HIMSS 2019. Dr. Rosenbloom’s talk, “Implementing Precision Medicine in the Clinical Setting: Challenges and Rewards” expounds on:Pharmacogenomics’...
read more
Precision without Fatigue: Focusing on User-experience and Technology to Improve Patient Outcomes
PEPID’s Executive Vice President and Chief Technology Officer, Edward Reynolds joins the Pulse during HIMSS 2019 to talk about the development strategy and objectives behind the company’s most cutting-edge release. His talk, “Precision without Fatigue: Focusing on...
read more
Untapped Support: Certified Pharmacy Technicians for More Efficient Pharmacies
Today’s healthcare industry is a race between technology, policy, and support, with the endpoint for all of them being a more patient-centered approach. Technological advancements have made precision medicine possible, resulting in an explosion of data and...
read more
Keep Your Genes On: How to Set Patients’ Expectations of PGx Testing
Moving Forward with Proper PGx Expectations 2,5Pharmacogenomic (PGx) testing and PGx-based treatments may be all the rage in precision medicine today, but more genetic and pharmacology experts – especially in the areas of cardiology, pain management, and...
read more
Expanding Services and Savings: Why Leveraging a Remote Pharmacy is a Win-Win
Moving Forward with Remote SupportThe intimidating costs behind patient-centered healthcare reform can be mitigated with the added revenue and reduced labor costs of establishing remote pharmacy models (RPMs). These highly efficient sites not only give...
read more
Trump Signs Opioid Law; Pharmacists Still Frustrated with Lack of Medicare B Coverage
Moving Forward with New Provisions The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (H.R. 6), signed on October 24, 2018, addresses the opioid crisis by reducing supply and access...
read more
Getting a Bigger Slice of the P.I.E.: The Pharmacist’s Duties in Clinical Pharmacogenomics (PGx)
Getting a Bigger Slice of the P.I.E.: The Pharmacist’s Duties in Clinical Pharmacogenomics (PGx) Ninety percent of Americans live within 5 miles of a community pharmacy, with local patients averaging 35 drugstore visits annually. Compared to the average...
read more
PGx + CDSS: Completing the Formula for Expanded Affordable Quality Healthcare
Pharmacogenomics (PGx) is rapidly evolving from being a “luxury” diagnostic test to the healthcare standard millions of patients and providers have been waiting for. Although PGx is a relatively new field, the R&D support and buzz behind it is growing...
read more
Patient-Centered Care & Barriers to Adherence
While medical R&D has been making great strides in precision medicine and pharmacogenetics – ultimately tailoring diagnostics and treatments to match individuals on a submolecular level – healthcare providers need to remember that their relationships...
read more
Association Of Exercise With Mortality In Adults Who Survived Childhood Cancer
A recent study of adults who survived childhood cancer revealed increased exercise (with a mean of 7.9 Metabolic Equivalent Task) over eight years was associated with 40% reduction in all-cause mortality rate when compared to low maintenance of...
read more
CMS Reshapes and Finalizes “Promoting Interoperability” Rule as Providers Transition to Stage 3 in 2019
Following the Centers for Medicare & Medicaid Services’ (CMS) April 2018 rule proposal comes the finalization of the “Promoting Interoperability” rule (PI, formerly known as the Meaningful Use program). CMS hopes that by reshaping the rule to be more concise and...
read more
Annual World Breastfeeding Week and the Benefits of Breastfeeding
August kicks off with World Breastfeeding Week, now on its 27th year since it was first celebrated by the World Alliance for Breastfeeding Action (WABA) in 1992. Every August 1-7, WABA partners with a worldwide network of organizations to encourage...
read more
FDA Grants Approval for First Targeted Anticancer Treatment for Relapsed or Refractory Acute Myeloid Leukemia with IDH1 Mutation
On July 20, 2018, the U.S. Food and Drug Administration (FDA) approved the first acute myeloid leukemia treatment. It is the first approved targeted cancer therapy for patients with relapsed or refractory acute myeloid leukemia (R/R AML), specifically,...
read morePEPID Announces its Participation in the 2018 ACEP Scientific Assembly
Phoenix, AZ, USA, August 1, 2018 — Medical information and clinical solutions developer, PEPID, LLC, will attend the largest emergency medicine (EM) convention in the country. The annual American College of Emergency Physicians (ACEP) Scientific Assembly will take...
read more